UCB trades 7.6% below Wall Street's consensus target of $38.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UCB achieves its forward estimates and maintains a stable P/E multiple of 12.0x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 28, 2026, United Community Banks, Inc. (UCB) has a Wall Street consensus price target of $38.33, based on estimates from 7 covering analysts. With the stock currently trading at $35.61, this represents a potential upside of +7.6%. The company has a market capitalization of $4.26B.
Analyst price targets range from a low of $35.00 to a high of $40.00, representing a 13% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, UCB trades at a trailing P/E of 13.6x and forward P/E of 12.0x. The forward PEG ratio of 1.85 indicates reasonable valuation for growth. Analysts expect EPS to grow +4.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $43.02, with bear and bull scenarios of $27.10 and $56.69 respectively. Model confidence stands at 46/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
SFNCSimmons First National Corporation | $3.3B | $22.93 | $23.00 | +0.3% | Buy | 11.1x | 9 |
HOMBHome Bancshares, Inc. | $5.9B | $29.30 | $31.50 | +7.5% | Hold | 11.9x | 19 |
SRCE1st Source Corporation | $2.0B | $81.96 | $81.00 | -1.2% | Hold | 12.0x | 4 |
GABCGerman American Bancorp, Inc. | $1.8B | $47.65 | $48.00 | +0.7% | Hold | 12.7x | 8 |
CBSHCommerce Bancshares, Inc. | $8.4B | $57.79 | $58.50 | +1.2% | Hold | 14.1x | 15 |
BOKFBOK Financial Corporation | $8.5B | $139.10 | $132.00 | -5.1% | Hold | 13.5x | 21 |
IBCPIndependent Bank Corporation | $747M | $36.23 | $38.00 | +4.9% | Hold | 10.2x | 7 |
NBTBNBT Bancorp Inc. | $2.6B | $49.59 | $56.00 | +12.9% | Hold | 11.9x | 10 |
WSFSWSFS Financial Corporation | $4.0B | $77.36 | $79.00 | +2.1% | Hold | 12.4x | 13 |
TRMKTrustmark Corporation | $2.7B | $46.59 | $45.50 | -2.3% | Hold | 11.9x | 9 |
Quick answers to the most common questions about buying UCB stock.
The consensus price target for UCB is $38.33, close to the current price of $35.61 (7.6% implied move). Based on 7 analyst estimates, the stock appears fairly valued near current levels.
UCB has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $38.33 implies 7.6% upside from current levels.
With a forward P/E of 12.0479x, UCB trades at a relatively low valuation. The consensus target of $38.33 implies 7.6% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $40 for UCB, while the most conservative target is $35. The consensus of $38.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $57 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UCB is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UCB stock forecast based on 7 Wall Street analysts shows a consensus price target of $38.33, with estimates ranging from $35 (bear case) to $40 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $43, with bear/bull scenarios of $27/$57.
Our quantitative valuation model calculates UCB's fair value at $43 (base case), with a bear case of $27 and bull case of $57. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.
UCB trades at a forward P/E ratio of 12.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
UCB appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $38.33 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UCB analyst price targets range from $35 to $40, a 13% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $38.33 consensus represents the middle ground. Our model's $27-$57 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.